|
VI. PHARMACOLOGICAL APPROACH
There have been very few advances in the pharmacological
management of itch. Oral antihistamines have been the backbone
of therapy. However, less than half of patients with itch do
not have adequate control with antihistamines.1-5, 13-15
The H1 receptor antagonists are the agents most commonly
used. Diphenhydramine (Benadryl) and hydroxazine (Atarax) are
the most common. Cetirizinc (Zyrtec) has also been used, a
selective H1 receptor antagonist as has Cimetidine, an H2
receptor antagonist with some success.13
- Topical Anesthetic Agents
The local anesthetic EMLA is composed of a 1:1 mixture of
lidocaine and prilocaine. Its use for itch has not been well
studied. However, the size of the wound will need to be
relatively small given the expense and absorption of the
lidocaine.13
Often narcotics or non-steroidal anti-inflammatory agents
are used in an attempt to control discomfort. Neither will
directly improve itch but can decrease the perception by a
sedating effect. In addition, an element of pain may also be
present.1-6
- Topical Doxepin Cream15-21
Doxepin is a tricyclic antidepressant, which has extremely
potent antihistamine properties being 800 times more potent
than diphenhydramine. The parent drug Doxepin is a very safe
agent with the only side effect being some drowsiness. A 5%
Doxepin cream has been used for over 15 years in the treatment
of choice for itchy skin with excellent results.
Two recent studies in outpatient burn
patients with itch burn wounds have demonstrated a rapid and
significant decrease in itch and redness in the itchy wound
compared to oral antihistamines.21,22
In addition, when used over a 3-month
period over half of the patients using the Doxepin cream no
longer had an itching burn wound compared to less than 10% of
the oral antihistamine group. Therefore the Doxepin cream not
only decreased the itch, but also altered the wound so that
the itch went away.
(For more details, see; Experience with 5% Doxepin Cream, Section
VIII)
|